BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26371403)

  • 1. Intensity-Based Assessment of Microbubble-Enhanced Ultrasonography: Phase-Related Diagnostic Ability for Cellular Differentiation of Hepatocellular Carcinoma.
    Kondo T; Maruyama H; Kiyono S; Sekimoto T; Shimada T; Takahashi M; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Chiba T; Kanai F; Yokosuka O
    Ultrasound Med Biol; 2015 Dec; 41(12):3079-87. PubMed ID: 26371403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
    Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
    AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Contrast-enhanced Ultrasonography with Perflubutane for Determining Histologic Grade in Hepatocellular Carcinoma.
    Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Kaneoka Y; Maeda A; Okuda S; Otobe K; Takahashi K
    Ultrasound Med Biol; 2015 Dec; 41(12):3070-8. PubMed ID: 26360976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation.
    Feng Y; Qin XC; Luo Y; Li YZ; Zhou X
    Ultrasound Med Biol; 2015 Jun; 41(6):1553-60. PubMed ID: 25747937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of microbubble accumulation: a novel approach to discriminate between well-differentiated hepatocellular carcinomas and regenerative nodules.
    Maruyama H; Takahashi M; Sekimoto T; Kamesaki H; Shimada T; Kanai F; Yokosuka O
    Ultrasound Med Biol; 2012 Mar; 38(3):383-8. PubMed ID: 22261511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irregular Defects in Hepatocellular Carcinomas During the Kupffer Phase of Contrast-Enhanced Ultrasonography with Perfluorobutane Microbubbles: Pathological Features and Metastatic Recurrence After Surgical Resection.
    Nuta J; Shingaki N; Ida Y; Shimizu R; Hayami S; Ueno M; Fukatsu K; Itonaga M; Yoshida T; Maeda Y; Moribata K; Deguchi H; Maekita T; Iguchi M; Kato J; Yamaue H; Tamai H
    Ultrasound Med Biol; 2017 Sep; 43(9):1829-1836. PubMed ID: 28625558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas.
    Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Kaneoka Y; Maeda A; Okuda S; Otobe K; Takahashi K
    Eur Radiol; 2014 Sep; 24(9):2157-66. PubMed ID: 24952601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas--correlation with histological differentiation.
    Strobel D; Kleinecke C; Hänsler J; Frieser M; Händl T; Hahn EG; Bernatik T
    Ultraschall Med; 2005 Aug; 26(4):270-6. PubMed ID: 16123920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of sequential imaging of hepatocellular carcinoma by contrast-enhanced power Doppler ultrasonograpy.
    Suzuki Y; Fujimoto Y; Hosoki Y; Suzuki M; Sakurai S; Ohhira M; Saito H; Kohgo Y
    Eur J Radiol; 2003 Nov; 48(2):214-9. PubMed ID: 14680917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases.
    Maruyama H; Takahashi M; Ishibashi H; Yoshikawa M; Yokosuka O
    Br J Radiol; 2012 Apr; 85(1012):351-7. PubMed ID: 21224305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Degree of Contrast Washout on Contrast-Enhanced Ultrasound in Distinguishing Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma.
    Han J; Liu Y; Han F; Li Q; Yan C; Zheng W; Wang J; Guo Z; Wang J; Li A; Zhou J
    Ultrasound Med Biol; 2015 Dec; 41(12):3088-95. PubMed ID: 26386477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between enhancement pattern of hepatocellular carcinoma on real-time contrast-enhanced ultrasound and tumour cellular differentiation on histopathology.
    Liu GJ; Xu HX; Lu MD; Xie XY; Xu ZF; Zheng YL; Liang JY
    Br J Radiol; 2007 May; 80(953):321-30. PubMed ID: 17005515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease.
    Numata K; Fukuda H; Nihonmatsu H; Kondo M; Nozaki A; Chuma M; Morimoto M; Oshima T; Okada M; Murakami T; Takebayashi S; Maeda S; Inayama Y; Nakano M; Tanaka K
    Abdom Imaging; 2015 Oct; 40(7):2372-83. PubMed ID: 26099473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma.
    Maruyama H; Takahashi M; Ishibashi H; Okabe S; Yoshikawa M; Yokosuka O
    Eur J Radiol; 2010 Jul; 75(1):e102-6. PubMed ID: 19783392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of Perfusion Parameters for Differentiating Hepatocellular Carcinoma and Liver Metastasis With Hypervascularity and a Normal Hepatic Background on Contrast-Enhanced Ultrasound Imaging.
    Lu Q; Zhang XL; Han H; Huang BJ; Ding H; Wang WP
    J Ultrasound Med; 2019 Oct; 38(10):2601-2608. PubMed ID: 30697787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mechanical index post-contrast ultrasonography improves tissue structural display of hepatocellular carcinoma.
    Chen MH; Yang W; Dai Y; Wu W
    Chin Med J (Engl); 2005 Dec; 118(24):2046-51. PubMed ID: 16438901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corona enhancement in ultrasonographical post-vascular phase images with microbubble contrast agent: a novel specific sign for hepatocellular carcinomas.
    Yamamoto K; Nakanishi S; Fuke H; Hashimoto A; Shimizu A; Hamataki T; Shiraki K
    Oncol Rep; 2006 Apr; 15(4):785-90. PubMed ID: 16525659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfusion Characteristics of Hepatocellular Carcinoma at Contrast-enhanced Ultrasound: Influence of the Cellular differentiation, the Tumor Size and the Underlying Hepatic Condition.
    Yang D; Li R; Zhang XH; Tang CL; Ma KS; Guo DY; Yan XC
    Sci Rep; 2018 Mar; 8(1):4713. PubMed ID: 29549368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging.
    Takahashi M; Maruyama H; Shimada T; Kamezaki H; Sekimoto T; Kanai F; Yokosuka O
    Eur J Radiol; 2013 Jan; 82(1):75-84. PubMed ID: 23116806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal hepatic lesions: contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent.
    Kim EA; Yoon KH; Lee YH; Kim HW; Juhng SK; Won JJ
    Korean J Radiol; 2003; 4(4):224-33. PubMed ID: 14726639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.